Premium
P1–104: Assessing the effects of memantine in APP/PS1 transgenic mice by behavioral studies and ex vivo imaging of amyloid plaques using gadolinium labeled amyloid β peptides and micromri
Author(s) -
Wisniewski Thomas,
Scholtzova Henrieta,
Wadghiri Youssef Z.,
Sigurdsson Einar M.,
Douadi Moustafa,
Li Yongsheng,
Quartermain David,
Banerjee Pradeep K.
Publication year - 2006
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2006.05.480
Subject(s) - memantine , ex vivo , genetically modified mouse , nmda receptor , neuroprotection , pharmacology , in vivo , neurotoxicity , amyloid (mycology) , barnes maze , medicine , amyloid precursor protein , chemistry , pathology , alzheimer's disease , transgene , endocrinology , receptor , toxicity , biology , in vitro , biochemistry , disease , hippocampus , spatial learning , microbiology and biotechnology , gene